SCHEMBL7130422

SCHEMBL7130422

CNS(=O)(=O)c1ccc2c(c1)C(=Cc1ccc(C(C)C)cc1)C(=O)N2

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.59
ERBB2 P04626 1/20 0.59
IGF1R P08069 1/20 0.59
PDGFRB P09619 1/20 0.59
GLB1 P16278 1/20 0.59
CTRC Q99895 1/20 0.59
SRC P12931 3/20 0.55
CDK2 P24941 2/20 0.53
KDR P35968 1/20 0.52
NTRK1 P04629 1/20 0.50
FCER2 P06734 1/20 0.50
SYK P43405 1/20 0.50
NTRK3 Q16288 1/20 0.50
NTRK2 Q16620 1/20 0.50
APP P05067 1/20 0.49
MAPT P10636 1/20 0.49
SIRT2 Q8IXJ6 1/20 0.48
SIRT1 Q96EB6 1/20 0.48
SIRT5 Q9NXA8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7136913 0.88 LRRK2 (0.57) SRCCDK2KDRNTRK1FCER2
SCHEMBL7136883 0.87 SRC (0.58) PDGFRBSRCCDK2KDRNTRK1
SCHEMBL5365190 0.86 PSEN1 (0.60) PDGFRBSRCCDK2KDRAPP
SCHEMBL5369843 0.86 SRC (0.59) PDGFRBSRCCDK2KDRNTRK1
SCHEMBL5365022 0.84 SRC (0.55) PDGFRBSRCCDK2KDRNTRK1
SCHEMBL5361448 0.84 SYK (0.65) SRCCDK2KDRNTRK1FCER2
SCHEMBL7132147 0.84 SRC (0.55) PDGFRBSRCCDK2KDRNTRK1
SCHEMBL7130343 0.84 SRC (0.55) SRCCDK2KDRNTRK1FCER2
SCHEMBL7135152 0.84 SRC (0.55) PDGFRBSRCCDK2KDRNTRK1
SCHEMBL7138289 0.84 SRC (0.58) PDGFRBSRCCDK2KDRNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed
EP-0984930-A1 2-INDOLINONE DERIVATIVES AS MODULATORS OF PROTEIN KINASE ACTIVITY Sugen, Inc. (US) 2000-03-15 EP disclosed
WO-1998050356-A1 2-INDOLINONE DERIVATIVES AS MODULATORS OF PROTEIN KINASE ACTIVITY SUGEN, INC. (US) 1998-11-12 WO disclosed